Why the study?
Does PAR-1 activation stimulate epithelial chloride secretion through a MAP kinase and COX-dependent pathway in SCBN intestinal epithelial cells?
Does PAR-1 activation stimulate epithelial chloride secretion through a MAP kinase and COX-dependent pathway in SCBN intestinal epithelial cells?
PAR-1-induced chloride secretion in intestinal epithelial cells involves a complex signaling pathway including Src, EGF receptor trans-activation, MAPK, cPLA2, and COX activity, which may be relevant in inflammatory intestinal diseases.
PAR-1 chloride secretion proceeds via Src-EGF-MAPK-cPLA2-COX in intestinal epithelia; leaves open relevance to human inflammatory disease.
Proteinase-activated receptor 1 (PAR-1) is activated by thrombin and induces chloride secretion by intestinal epithelial cells. To elucidate further the mechanisms whereby PAR-1 stimulates secretion, monolayers of SCBN intestinal epithelial cells were studied in modified Ussing chambers. Short circuit current responses were determined after basolateral application of thrombin and the PAR-1-activating peptide, Ala-parafluoro-Phe-Arg-cyclohexyl-Ala-Citrulline-Tyr (Cit-NH2) in the presence or absence of a variety of signal transduction and cyclo-oxygenase (COX) pathway inhibitors. Increased kinase activity was monitored by immunoprecipitation and Western blot analysis of target phosphoproteins. The PAR-1-induced chloride secretory response was significantly attenuated by inhibitors of the EGF receptor tyrosine kinase, Src-kinase, MEK1/2, as well as by inhibitors of cytosolic phospholipase (cPL) A2, COX-1 and COX-2. PAR-1-induced activation of cPLA2, as shown by Western blot of phosphoserine residues, was blocked in cells treated with the MEK inhibitor U0126, indicating that the MEK-ERK1/2 MAP kinase pathway mediated PAR-1-induced cPLA2 phosphorylation. Our data show that PAR-1-induced chloride secretion in SCBN cells involves Src, EGF receptor trans-activation, activation of a MAPK pathway, phosphorylation of cPLA2, COX activity, but not PGF2alpha or PGE2. These findings may be of clinical importance in inflammatory diseases of the intestine where secretory dysfunction is evident and thrombin levels are elevated.
No takes yet. Share an insight, caveat, or question.
Buresi et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: